AGTC Reports Encouraging Interim Six-Month Data from the Dose Escalation Cohorts of its Ongoing Phase 1/2 Clinical Trials in AchromatopsiaGlobeNewsWire • 01/23/20
Applied Genetic Technologies Should Be On Your Radar After Latest Rare Disease Eye DataSeeking Alpha • 01/10/20
Implied Volatility Surging for Applied Genetic Technologies (AGTC) Stock OptionsZacks Investment Research • 01/10/20
Applied Genetic Shares Rip Higher After Eye Disorder Gene Therapy Aces Midstage TrialBenzinga • 01/09/20
AGTC Reports Positive Six-Month Data from its Ongoing Phase 1/2 Clinical Trial in X-Linked Retinitis PigmentosaGlobeNewsWire • 01/09/20
Applied Genetics Technology Corporation: Strong Science And Clinical EfficacySeeking Alpha • 12/03/19
AGTC Announces Departure of Chief Medical Officer, Company on Track to Announce XLRP and ACHM Data in January 2020GlobeNewsWire • 12/02/19
Applied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/13/19
AGTC Presents Data Demonstrating Efficiency of its AAV Vectors for Ocular Gene Therapy Even in the Presence of Anti-AAV AntibodiesGlobeNewsWire • 10/21/19
AGTC and Otonomy Announce Strategic Collaboration to Develop and Commercialize Gene Therapy for Congenital Hearing LossGlobeNewsWire • 10/01/19
Applied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 09/27/19
Applied Genetic Technologies (AGTC) Reports Q4 Loss, Lags Revenue EstimatesZacks Investment Research • 09/26/19
AGTC Announces Financial Results and Business Update for the Fourth Quarter and Fiscal Year Ended June 30, 2019GlobeNewsWire • 09/26/19
Analysts Estimate Applied Genetic Technologies (AGTC) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 09/19/19
Applied Genetic Technologies Corporation (AGTC) CEO SueWasher on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/07/19
Applied Genetic Technologies (AGTC) Q3 Earnings and Revenues Surpass EstimatesZacks Investment Research • 05/07/19
Applied Genetic Technologies (AGTC) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 04/09/19